# Boston Scientific Corporation (BSX) — Q2-2024 Earnings Results

**Report date:** 2024-07-24 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q2-2024

## Post-Earnings Brief

### Headline

Boston Scientific Beats on EPS, Stock Down 1.06%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.62 | N/A | +6.90% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed confidence in their product pipeline and operational strategies. They acknowledged challenges but remain focused on long-term growth.

**Key quotes:**

> Management highlighted ongoing innovation as a key driver for future growth.

> They emphasized the importance of maintaining strong operational efficiency.

> There was a focus on expanding market share in key segments.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Boston Scientific's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 1.06% following the announcement, likely due to the lack of revenue details and guidance. Investors may be cautious as the company navigates market challenges while pursuing growth opportunities.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q2-2024_